Your browser doesn't support javascript.
loading
Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamics.
Wang, Xue; Liu, Junnan; Azoitei, Anca; Eiseler, Tim; Meessen, Sabine; Jiang, Wencheng; Zheng, Xi; Makori, Arika W; Eckstein, Markus; Hartmann, Arndt; Stilgenbauer, Stephan; Elati, Mohamed; Hohwieler, Meike; Kleger, Alexander; John, Axel; Zengerling, Friedemann; Wezel, Felix; Bolenz, Christian; Günes, Cagatay.
Afiliação
  • Wang X; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Liu J; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
  • Azoitei A; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Eiseler T; Department of Urology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
  • Meessen S; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Jiang W; Department of Internal Medicine I, University Hospital, Ulm, Germany.
  • Zheng X; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Makori AW; Division of Hepatology, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Eckstein M; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Hartmann A; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Stilgenbauer S; Department of Urology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, Jiangsu, China.
  • Elati M; Institute of Urology, Nanjing University, Nanjing, 210008, Jiangsu, China.
  • Hohwieler M; Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
  • Kleger A; Institute of Pathology, Friedrich-Alexander University, Erlangen, Germany.
  • John A; Institute of Pathology, Friedrich-Alexander University, Erlangen, Germany.
  • Zengerling F; Department of Internal Medicine III, University Hospital, Ulm, Germany.
  • Wezel F; CANTHER, ONCOLille Institute, University of Lille, CNRS UMR 1277, Inserm U9020, 59045, Lille Cedex, France.
  • Bolenz C; Institute of Mol. Oncology and Stem Cell Biology, University Hospital, Ulm, Germany.
  • Günes C; Institute of Mol. Oncology and Stem Cell Biology, University Hospital, Ulm, Germany.
Cell Mol Life Sci ; 80(10): 299, 2023 Sep 22.
Article em En | MEDLINE | ID: mdl-37740130
ABSTRACT
We have recently shown that loss of ORP3 leads to aneuploidy induction and promotes tumor formation. However, the specific mechanisms by which ORP3 contributes to ploidy-control and cancer initiation and progression is still unknown. Here, we report that ORP3 is highly expressed in ureter and bladder epithelium while its expression is downregulated in invasive bladder cancer cell lines and during tumor progression, both in human and in mouse bladder cancer. Moreover, we observed an increase in the incidence of N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-induced invasive bladder carcinoma in the tissue-specific Orp3 knockout mice. Experimental data demonstrate that ORP3 protein interacts with γ-tubulin at the centrosomes and with components of actin cytoskeleton. Altering the expression of ORP3 induces aneuploidy and genomic instability in telomerase-immortalized urothelial cells with a stable karyotype and influences the migration and invasive capacity of bladder cancer cell lines. These findings demonstrate a crucial role of ORP3 in ploidy-control and indicate that ORP3 is a bona fide tumor suppressor protein. Of note, the presented data indicate that ORP3 affects both cell invasion and migration as well as genome stability through interactions with cytoskeletal components, providing a molecular link between aneuploidy and cell invasion and migration, two crucial characteristics of metastatic cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Actinas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Actinas Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article